Skip to content

The FRANK friends study: a multicentre cluster randomised controlled trial evaluating a school-based drug prevention intervention

A multicentre cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of a school-based peer-led drug prevention intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72047541
Enrollment
7242
Registered
2019-08-23
Start date
2019-09-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of illicit drugs Not Applicable

Interventions

Current interventions as of 09/01/2020: This trial will introduce and evaluate FRANK Friends (the “intervention”) which is a school-based peer-led drug prevention intervention. In each

Sponsors

Cardiff University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Students in UK Year 9 (aged 13-14)

Exclusion criteria

Exclusion criteria: 1. Fee-paying schools 2. Special schools (e.g. for those with learning disabilities) 3. Pupil referral units 4. Schools with less than 60 students in Year 9 5. Schools likely to be closed or merged during the trial 6. Those that received the FRANK friends intervention in the pilot

Design outcomes

Primary

MeasureTime frame
Lifetime illicit drug use is assessed using a self-report questionnaire at baseline and a 24-month follow-up

Secondary

MeasureTime frame
1. The use of any illicit drug over the past 12 months, past month and week assessed using self-report questionnaires at baseline and a 24-month follow-up 2. The use of specific illicit drugs over the past 12 months, past month and week assessed using self-report questionnaires at baseline and a 24-month follow-up 3. The frequency of use of any illicit drug over the past 12 months, past month and week assessed using self-report questionnaires at baseline and a 24-month follow-up 4. The frequency of use of specific illicit drugs over the past 12 months, past month and week assessed using self-report questionnaires at baseline and a 24-month follow-up. 5. Cannabis dependency assessed using the Cannabis Abuse Screen Test (CAST) at baseline and a 24-month follow-up 6. Smoking (lifetime and weekly smoking status) assessed using a self-report questionnaire at baseline and a 24-month follow-up (weekly smoking defined as usually smoking = one cigarette a week) 7. The frequency of alcohol consumption (past 12 months, month and week) assessed using a self-report questionnaire at baseline and a 24-month follow-up 8. Alcohol use disorder defined as consuming = 3 whole alcoholic drinks in the past year using a self-report on the frequency of alcohol consumption at baseline and a 24-month follow-up 9. Health-related quality of life assessed using the Child Health Utility 9D using a self-report questionnaire at baseline and a 24-month follow-up

Countries

England, United Kingdom, Wales

Contacts

Public ContactJames White
whitej11@cf.ac.uk+44 (0)29 20 687054

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026